AbbVie Stock News
$185.58
1.33%
yesterday
NYSE,
May 08, 10:10 pm CET
AbbVie Stock News
Neutral
GlobeNewsWire
●
one day ago
NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV).
Neutral
PRNewsWire
●
3 days ago
NORTH CHICAGO, Ill. , May 6, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025.
Positive
CNBC
●
3 days ago
President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S. The order comes ahead of Trump's planned tariffs on pharmaceuticals imported into the U.S.
Negative
The Motley Fool
●
5 days ago
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns usually don't affect drugmakers' underlying businesses much, if at all.
Positive
Investors Business Daily
●
7 days ago
Positive post-earnings and a general upward draft of price action in the markets make for a strong argument for a bullish setup on AbbVie.
Neutral
MarketBeat
●
7 days ago
In today's unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability. That means turning to assets that can hold up under pressure, especially those that don't rely too heavily on international markets.
Neutral
PRNewsWire
●
7 days ago
BOTOX® Cosmetic Will Provide 250 Entrepreneurs with Access to New Resources and Opportunities and Will Award 20 Grants Worth $20,000 Each to Support Business Goals. By 2030, BOTOX® Cosmetic Pledges to Empower 50,000 Entrepreneurs, Helping to Close the Confidence Gap.
Positive
CNBC
●
8 days ago
Tariff threats are fueling a new wave of U.S. manufacturing investments from the pharmaceutical industry.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
